Increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Effect of N omega-nitro-L-arginine.
- 1 November 1991
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 18 (5) , 683-688
- https://doi.org/10.1161/01.hyp.18.5.683
Abstract
We investigated the role of nitric oxide (NO)-dependent and NO-independent mechanisms in mediation of renal vasodilatory responses to bradykinin in spontaneously hypertensive rats (SHR), rats with angiotensin II-induced hypertension (200 ng/min i.p. for 6 days) and the corresponding normotensive control Wistar-Kyoto (WKY) rats and sham-infused rats. To this end, we contrasted the effects of arterial injections of bradykinin and other vasodilators, acetylcholine and sodium nitroprusside, on perfusion pressure and output of cyclic GMP in isolated kidneys perfused with Krebs bicarbonate buffer containing phenylephrine, both with and without N omega-nitro-L-arginine (L-NOARG) (50 microM), an inhibitor of NO synthetase. In kidneys perfused without L-NOARG, all agonists increased the output of cyclic GMP and reduced perfusion pressure, indicative of vasodilation. In kidneys perfused with L-NOARG, vasodilatory responses to bradykinin and acetylcholine were attenuated, and associated effects on output of cyclic GMP were abolished, suggesting dependency on NO synthesis. Irrespective of whether kidneys were perfused with or without L-NOARG, kidneys of SHR were more responsive than kidneys of WKY rats with regard to bradykinin-induced vasodilation. In contrast, vasodilatory responsiveness to bradykinin was nearly equal in perfused kidneys of rats with angiotensin II-induced hypertension and in normotensive controls. Also, vasodilatory responsiveness to acetylcholine and sodium nitroprusside was similar in kidneys of normotensive and hypertensive rats. These data suggest that the renal vasculature of SHR is uniquely and selectively hyperresponsive to bradykinin, with regard to both the NO-dependent and NO-independent vasodilatory actions.Keywords
This publication has 17 references indexed in Scilit:
- l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitroBritish Journal of Pharmacology, 1990
- Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formationEuropean Journal of Pharmacology, 1990
- Regional Vascular Resistance and Haemodynamics in the Spontaneously Hypertensive RatJournal of Cardiovascular Pharmacology, 1990
- Indirect evidence for an endothelium-derived contracting factor released in arterioles of deoxycorticosterone acetate salt hypertensive ratsJournal Of Hypertension, 1990
- Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formationBritish Journal of Pharmacology, 1989
- Endothelium-dependent relaxation in resistance vessels from the spontaneously hypertensive ratsJournal Of Hypertension, 1989
- Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats.Hypertension, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The loss of endothelium-dependent vascular relaxation in hypertension.Hypertension, 1986
- Role of endothelium in dilator responses of spontaneously hypertensive rat arteries.Hypertension, 1983